Comparing endoscope-assisted versus burr-hole drainage for chronic subdural hematoma
Official title: Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma: A Multicenter Randomized Controlled Trial, URANUS
Run by Beijing Tiantan Hospital · NCT07144423 · Data updated 2026-11-12
This trial will test whether endoscope-assisted drainage works better than standard burr-hole drainage for adults (18–90) with symptomatic, imaging-confirmed chronic subdural hematoma.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 770 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 24 sites (Beijing, Beijing Municipality and 23 other locations) |
| Status | Recruiting |
| Started | November 19, 2025 |
| Main results expected | July 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 9, 2026 |
| Trial ID | NCT07144423 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 to 90 with symptomatic, CT- or MRI-confirmed chronic subdural hematoma who are judged to need surgical drainage and can provide informed consent are ideal candidates.
✕Probably not a fit
Patients without clinical symptoms or mass effect (midline shift < 5 mm), those who cannot tolerate surgery because of severe comorbidities or coagulopathy, or those with recent intracranial surgery are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, randomized comparison of neuroendoscopy-assisted hematoma evacuation versus conventional burr-hole drainage for chronic subdural hematoma. Patients with symptomatic, imaging-confirmed CSDH who require surgical drainage will be randomized to one of the two procedures and followed for postoperative recurrence, drainage duration, and neurological outcomes. Neuroendoscopy allows direct visualization to irrigate, aspirate, and cut septations, which may reduce residual hematoma compared with blind burr-hole drainage. The trial aims to determine which approach produces lower recurrence rates and faster recovery across several Chinese neurosurgical centers.
Why it matters
Potential benefit: If successful, the endoscope-assisted approach could lower recurrence rates, shorten drainage time, and improve neurological recovery after CSDH surgery.
How similar studies have gone: Smaller observational and single-center reports have suggested neuroendoscopy can reduce recurrence and drainage duration, but large multicenter randomized evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient (18 years to 90 years) presenting with clinical symptoms and neurological deficits of CSDH. 2. CSDH verified on cranial computed tomography or magnetic resonance imaging. 3. Written informed consent from patients or their next of kin according to the patient's cognitive status. Exclusion Criteria: 1. No clinical symptoms correlating with chronic subdural hematoma. 2. Lack of mass effect and midline shift \< 5 mm on the radiological image, or no need surgery judged clinically by neurosurgeons. 3. Previous surgery for CSDH during the past 6 months. 4. Previous intracranial surgery for any other neurological disorder. 5. Poor medication conditions or the presence of severe comorbidities so that surgery cannot be tolerated, or follow-up cannot be completed. 6. Severe coagulopathy or a high risk of life-threatening bleeding (including any one of the following three criteria: prothrombin time or activated partial thromboplastin time prolonged by more than 10 seconds; international normalized ratio \> 3.0; absolute platelet count \< 100×109/L). 7. Postoperative compliance is suspected to be insufficient for 3-month follow-up visit. 8. Reproductive-age women without verified negative pregnancy testing. 9. Participating in another research.
Where it's running
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting -
First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China Recruiting -
Jiangmen Central Hospital
Jiangmen, Guangdong, China Recruiting -
Shantou central hosital
Shantou, Guangdong, China Recruiting -
People's Hospital of Longhua, Shenzhen
Shenzhen, Guangdong, China Recruiting -
Liuzhou worker's Hospital
Liuzhou, Guangxi, China Recruiting
Show 18 more locations
-
The Second Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China Recruiting -
Nanning First People's Hospital
Nanning, Guangxi, China Recruiting -
The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
Nanning, Guangxi, China Recruiting -
Wuzhou Gongren Hospital
Wuzhou, Guangxi, China Recruiting -
Hebei University of Engineering Affiliated Hospital
Handan, Hebei, China Recruiting -
Xingtai Central Hospital
Xingtai, Hebei, China Recruiting -
Changde First People's Hospital
Changde, Hunan, China Recruiting -
People's Hospital of Xiangxi Prefecture, Hunan Province
Jishou, Hunan, China Recruiting -
Yueyang Central Hospital
Yueyang, Hunan, China Recruiting -
Heji Hospital affiliated with Changzhi Medical College
Changzhi, Shanxi, China Recruiting -
Linfen People's Hospital
Linfen, Shanxi, China Recruiting -
Shanxi Provincial People's Hospital,Shanxi Medical University
Taiyuan, Shanxi, China Recruiting -
The Second Affiliated Hospital of Xi'an Medical University
Xi’an, Shanxi, China Recruiting -
Mianyang 404 Hospital
Mianyang, Sichuan, China Recruiting -
the First People'S Hospital of Yibin
Yibin, Sichuan, China Recruiting -
First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China Recruiting -
Pu'er People's Hospital
Pu'er, Yunnan, China Recruiting -
First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China Recruiting
Study contacts
- Principal investigator: Guoyi Gao, MD — Beijing Tiantan Hospital
- Study coordinator: Liang Wu, MD
- Email: jasewl@sina.com
- Phone: 18301674233
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Middle Meningeal Artery Embolisation to Prevent Recurrence of Chronic Subdural Hematoma
This study tests whether embolising the middle meningeal artery around the time of hematoma evacuation can reduce recurrence in adults with chronic subdural hematoma.
-
What causes vulnerability in older adults with serious diseases and how it affects care decisions
This study tests how often vulnerability factors appear in older adults with serious illnesses and how these factors influence treatment timing, survival, and quality of life.
-
Coil embolization for unilateral vs bilateral chronic subdural hematomas
This trial tests whether unilateral or bilateral coil-based embolization of the middle meningeal artery helps people with chronic subdural hematoma.
-
Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma
A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.
-
Enhanced recovery pathway for burr-hole drainage in chronic subdural hematoma patients
This project tests whether an enhanced recovery protocol for adults having burr-hole drainage for chronic subdural hematoma can reduce recurrence and complications compared with past patients.
-
Matched microcatheter and guidewire use for middle meningeal artery embolization in chronic subdural hematoma
This will test whether using a matched Aristotle 14 guidewire and Plato 17 microcatheter during middle meningeal artery embolization works better than surgeons' usual device choices for adults with chronic subdural hematoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.